| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |